Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revive Therapeutics Ltd (TSE:RVV)
CNQX:RVV
Holding TSE:RVV?
Track your performance easily
RVV Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.04
Previous CloseC$0.01
Volume57.72K
Average Volume (3M)465.74K
Market Cap
C$4.19M
Enterprise ValueC$3.44M
Total Cash (Recent Filing)C$773.07K
Total Debt (Recent Filing)C$25.22K
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding418,564,269
10 Day Avg. Volume446,753
30 Day Avg. Volume465,739
Standard Deviation0.37
R-Squared0.00129
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.50
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Revive Therapeutics News
PremiumCompany Announcements
Revive Therapeutics Explores Psilocybin for Stroke Treatment
PremiumCompany Announcements
Revive Therapeutics Prioritizes Bucillamine Development
PremiumCompany Announcements
Revive Therapeutics Explores Bucillamine for Nerve Agents and Viral Threats
PremiumCompany Announcements
Revive Therapeutics Tests Treatment for Nerve AgentsOptions Prices
Currently, No data available
---
Ownership Overview
0.88% Insiders
<0.01% Other Institutional Investors
99.12% Public Companies and
Individual Investors
RVV FAQ
What was Revive Therapeutics Ltd’s price range in the past 12 months?
Revive Therapeutics Ltd lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Revive Therapeutics Ltd’s market cap?
Currently, no data Available
When is Revive Therapeutics Ltd’s upcoming earnings report date?
Revive Therapeutics Ltd’s upcoming earnings report date is Feb 26, 2025 which is in 67 days.
How were Revive Therapeutics Ltd’s earnings last quarter?
Currently, no data Available
Is Revive Therapeutics Ltd overvalued?
According to Wall Street analysts Revive Therapeutics Ltd’s price is currently Overvalued.
Does Revive Therapeutics Ltd pay dividends?
Revive Therapeutics Ltd does not currently pay dividends.
What is Revive Therapeutics Ltd’s EPS estimate?
Revive Therapeutics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Revive Therapeutics Ltd have?
Revive Therapeutics Ltd has 418,564,270 shares outstanding.
What happened to Revive Therapeutics Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Revive Therapeutics Ltd?
Currently, no hedge funds are holding shares in TSE:RVV
---
Revive Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-66.66%
12-Months-Change
Fundamentals
Return on Equity
-66.98%
Trailing 12-Months
Asset Growth
-27.08%
Trailing 12-Months
Company Description
Revive Therapeutics Ltd
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
---
Technical Analysis
---